
GE HealthCare secured FDA 510(k) clearance for its Photonova Spectra, a next‑generation photon‑counting CT system featuring Deep Silicon 8‑bin energy resolution. The scanner processes data volumes up to 50 times larger than conventional CTs using Nvidia‑accelerated computing and rotates in 0.23 seconds for motion‑free imaging. Its high spatial and spectral resolution enhances visualization of vascular structures and lesions across oncology, cardiology, and neurology. The company will soon launch the system commercially in the United States.

IQVIA Holdings announced the launch of IQVIA.ai, a unified agentic AI platform built with Nvidia, aimed at the life‑sciences sector. The solution merges IQVIA’s healthcare‑grade AI and extensive data assets with Nvidia’s Nemotron models and NeMo Agent Toolkit, meeting strict...

UK Defence Science and Technology Laboratory and the US DARPA conducted AI‑enabled battlefield medical triage trials, testing whether AI can be aligned with individual medics' ethical preferences. Simulated mass‑casualty scenarios in October 2025 let participants evaluate AI decisions without knowing...

Whoop announced a $575 million financing round, backed by a Gulf sovereign‑wealth fund and Cristiano Ronaldo, to expand its wristband into continuous glucose monitoring. OpenAI completed one of the largest financial transactions in history, shelved its erotic chatbot project and repositioned itself...

Spacelabs Healthcare has signed an agreement with DEPTH Health to integrate its Rothman Index into DEPTH’s Real‑Time Advisor for Clinical Expert Routing (RACER) platform. The Rothman Index aggregates 26 clinical data points into a 200‑point risk score that updates continuously,...

ZS CEO Pratap Khedkar warns pharma must move from isolated AI pilots to scalable, high‑impact use cases such as clinical trials, commercialization, and supply‑chain intelligence. He cites a new ZS‑Healthcare Leadership Council report showing the sector is transitioning toward targeted...

Medvi, a two‑person GLP‑1 telehealth brand, posted $401 million in 2025 revenue and is on track for $1.8 billion in 2026, delivering a 16.2% net margin. The company built its consumer‑facing platform using AI tools for under $20,000, while outsourcing all clinical...

The healthcare AI market is facing a sharp correction, with Series B funding dropping 84% from its 2021 peak and 95% of enterprise pilots failing to show ROI. Most failures stem from demo‑centric tools that cannot survive fragmented clinical data environments....

Boston University, leading the AI for Alzheimer’s Disease (AI4AD) consortium, is coordinating 11 research institutes to apply machine learning to massive genomic, biomarker and cognitive datasets. The team is building the PreSiBO database, which tags predictor, signature, biomarker and outcome...

On March 31, 2026 a 59.8 MB source‑map file unintentionally exposed Anthropic’s Claude Code TypeScript codebase, revealing roughly 512,000 lines of production‑grade AI agent logic. The leak showcases a three‑layer skeptical memory system, a coordinator mode for multi‑agent orchestration, the AutoDream consolidation...
Researchers at Penn State used the Texas Advanced Computing Center's Stampede3 supercomputer, funded by NSF ACCESS, to run high‑resolution simulations of red blood cell deformation in mechanical circulatory support devices. By adapting a droplet deformation equation within OpenFOAM, the team...
Researchers at Tohoku University and City College of New York unveiled a nanotechnology‑based creatinine biosensor that reads concentrations from 1 to 300 mg/dL in about 35 seconds. The device uses a platinum‑nanoparticle polymer composite tuned near the percolation threshold, eliminating the...
The Futurist Global released a post‑conference report on ViVE 2026, drawing insights from 28 top digital‑health leaders. It highlights that physicians access only 3‑5% of patient data, while hospital data volumes are doubling every two years to roughly 50 petabytes per...
Amprion announced a strategic partnership with Macquarie University to launch Australia’s first clinical alpha‑synuclein seed amplification testing site, expanding its global footprint. The company will continue collaborative research with the Michael J. Fox Foundation in 2026, integrating its SAAmplify‑ɑSYN assay into...
The April 1, 2026 "Video Wednesday" post serves as a launchpad for a weekly video series that highlights cutting‑edge medical robotics and pandemic‑response technologies. It references earlier "Flickstop" entries that showcased robotic surgery and COVID‑19 disinfection robots, providing visual context for readers....